Atlas Trials

Intergroupe Francophone du Myelome

13 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Intergroupe Francophone du Myelome

RecordFirmDate
Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients (NCT06918002)Intergroupe Francophone du Myelome2025-07-09
Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple Myeloma Patients (NCT06062537)Intergroupe Francophone du Myelome2023-09-19
Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma (NCT05208086)Intergroupe Francophone du Myelome2022-05-18
Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy (NCT05066607)Intergroupe Francophone du Myelome2022-02-11
MInimal Residual Disease Adapted Strategy (NCT04934475)Intergroupe Francophone du Myelome2021-12-08
Analysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple Myeloma (NCT04805203)Intergroupe Francophone du Myelome2020-12-16
Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations. (NCT04144387)Intergroupe Francophone du Myelome2020-02-11
IPD in RRMM Characterized With Genomic Abnormalities of Adverse Prognostic (NCT03683277)Intergroupe Francophone du Myelome2019-11-03

Track Intergroupe Francophone du Myelome automatically

Every clearance here is in the API, with alerts when new ones post.